Richard C. Hubbard

11.0k citations

81 papers · 8.6k indexed · 4 hit papers · h-index 48

Pharmacology top 0.1%
- Inflammatory mediators and NSAID effects 29
Biochemistry top 0.5%
Anesthesiology and Pain Medicine top 0.5%
Pulmonary and Respiratory Medicine top 0.5%
- Neonatal Respiratory Health Research 10
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 9
- Inhalation and Respiratory Drug Delivery 8
Cancer Research top 2%
- Protease and Inhibitor Mechanisms 11
Surgery
- Anesthesia and Pain Management 14
Organic Chemistry
- Synthesis of β-Lactam Compounds 9
Oncology
- Peptidase Inhibition and Analysis 7

Co-authors: Ronald G. Crystal André M. Cantin Gilbert Geis Susan L. North G A Fells Peter C. Isakson Tricia M. McKeever Andrew Fogarty
Cited by: Pharmacology Biochemistry Anesthesiology and Pain Medicine
Journals: Journal of Clinical Investigation (8 papers)Journal of Applied Physiology (5 papers)Lung Cancer (4 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Richard C. Hubbard

77 papers receiving 8.2k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 European Respiratory Journal
1999 JAMA
1989 American Review of Respiratory Disease
1987 Journal of Applied Physiology

Peers

Countries citing papers authored by Richard C. Hubbard

Since Specialization

Citations

This map shows the geographic impact of Richard C. Hubbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Hubbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Hubbard more than expected).

Fields of papers citing papers by Richard C. Hubbard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C. Hubbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Hubbard. The network helps show where Richard C. Hubbard may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Richard C. Hubbard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard C. Hubbard Line = papers co-authored together Richard C. Hubbard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	What is the Definition of Cure in Non-small Cell Lung Cancer? Oncology and Therapy ·大野俊夫,Libby Ellis,Emma O’Dowd,Rachael L Murray,Richard C. Hubbard,David Baldwin	2021	8
2	P2.16-21 Post-Treatment Survival Difference Between Lobectomy and Stereotactic Ablative Radiotherapy in Stage 1 Non-Small Cell Lung Cancer in England Journal of Thoracic Oncology ·Aamir Khakwani,Susan Harden,Neal Navani,Paul Beckett,Richard C. Hubbard	2018	0
3	The Cyclooxygenase-2-Specific Inhibitor Parecoxib Sodium Is as Effective as 12 mg of Morphine Administered Intramuscularly for Treating Pain After Gynecologic Laparotomy Surgery Anesthesia & Analgesia ·T. Philip Malan,S. C. GORDON,Richard C. Hubbard,Michael C. Snabes	2005	37
4	A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy American Journal of Obstetrics and Gynecology ·George B. Bikhazi,Michael C. Snabes,Zahid H. Bajwa,Krishna Malakonda Reddy Parvathareddy,D Lecomte,Louise Traylor,Richard C. Hubbard	2004	38
5	Analgesic Efficacy of Preoperative Parecoxib Sodium in an Orthopedic Pain Model Journal of the American Podiatric Medical Association ·Paul J. Desjardins,Louise Traylor,Richard C. Hubbard	2004	29
6	Parecoxib Sodium, a Parenteral Cyclooxygenase 2 Selective Inhibitor, Improves Morphine Analgesia and Is Opioid-sparing following Total Hip Arthroplasty Anesthesiology ·T. Philip Malan,盛暉新崎,Francisco Javier Arias-Dachary,王少爽,Louise Traylor,Richard C. Hubbard	2003	125
7	Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia † British Journal of Anaesthesia ·Richard C. Hubbard,D.D. Donskoy,Nina Kosenok,Shobha Dhadda	2003	106
8	Intravenous parecoxib sodium foracute pain after orthopedic knee surgery. PubMed ·G. Lynn Rasmussen,Karen Steckner,Charles W. Hogue,Sarah Torri,Richard C. Hubbard	2002	66
9	Reduced Incidence of Gastroduodenal Ulcers With Celecoxib, A Novel Cyclooxygenase-2 Inhibitor, Compared To Naproxen in Patients With Arthritis The American Journal of Gastroenterology ·Jay L. Goldstein,P Corréa,Julia Winterlich,Aimee Burr,Richard C. Hubbard,R. Tacke,Gilbert Geis	2001	155
10	Increased Risk of Fibrosing Alveolitis Associated with Interleukin-1 Receptor Antagonist and Tumor Necrosis Factor- α Gene Polymorphisms American Journal of Respiratory and Critical Care Medicine ·Lin,Richard C. Hubbard,Riccardo Melicòni,Suprapto Suprapto,Ailao Tualauleleli,Colin D. Bingle,J. M. Timms,Gordon W. Duff,Karlheinz Huelser,Angela Maria Grazia Pacilli,Mario Fabbri,Ian P. Hall,John Britton,Ian Johnston,F Giovine	2000	141
11	Reduced Risk of Upper Gastrointestinal Ulcer Complications With Celecoxib, A Novel Cox-2 Inhibitor The American Journal of Gastroenterology ·Jay L. Goldstein,Fred E. Silverstein,Naurang M. Agrawal,Richard C. Hubbard,Bilas Sylwia,Clement Maurath,Kenneth M. Verburg,Long Jian-bo	2000	232
12	Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison The Lancet ·Paul Emery,H. Zeidler,Tore K Kvien,Mario Guslandi,Katherine Rogers-Carpenter,Helen Stead,Kenneth M. Verburg,Peter C. Isakson,Richard C. Hubbard,Gilbert Geis	1999	410
13	Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects Arthritis & Rheumatism ·Lee S. Simon,Frank L. Lanza,Peter E. Lipsky,Richard C. Hubbard,Sheela Talwalker,Benjamin D. Schwartz,Peter C. Isakson,Gilbert Geis	1998	405
14	Conversion from Twice-to Once-Daily Extended-Release Theophylline Treatment in Patients with Reversible Airway Obstruction Journal of Asthma ·Robert Berkowitz,David G. Tinkelman,Judith Marcoux,Anthony R. Rooklin,H Zeitz,Stephen I. Rennard,Joseph Impastato,Richard C. Hubbard,Richard Lorber	1995	2
15	Protease-Antiprotease Imbalance in the Lungs of Children with Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine ·P. Birrer,Noel G. McElvaney,A Rüdeberg,Mitsuru Nishiyama,Sabina Liechti‐Gallati,Richard Kraemer,Richard C. Hubbard,Ronald G. Crystal	1994	315
16	A Preliminary Study of Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis New England Journal of Medicine ·Richard C. Hubbard,Noel G. McElvaney,P. Birrer,Steven Shak,Timothy Dolch,鄭哲源,Margaret Wu,Milica S. Chernick,Ronald G. Crystal	1992	158
17	Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract. Journal of Clinical Investigation ·André M. Cantin,G A Fells,Richard C. Hubbard,Ronald G. Crystal	1990	108
18	Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency The American Journal of Medicine ·Richard C. Hubbard,Ronald G. Crystal	1988	53
19	Evaluation of the S-type of Alpha-1-Antitrypsin as an In Vivo and In Vitro Inhibitor of Neutrophil Elastase American Review of Respiratory Disease ·Fumitaka Ogushi,Richard C. Hubbard,G A Fells,Mario Casolaro,David T. Curiel,Mark Brantly,Ronald G. Crystal	1988	48
20	Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase. Journal of Clinical Investigation ·Fumitaka Ogushi,G A Fells,Richard C. Hubbard,أ.د. عياض عبد الرحمن أمين,Ronald G. Crystal	1987	161

About Richard C. Hubbard

Richard C. Hubbard is a scholar working on Pharmacology, Anesthesiology and Pain Medicine and Pulmonary and Respiratory Medicine, having authored 81 papers that have together received 8.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (29 papers), Anesthesia and Pain Management (14 papers), Protease and Inhibitor Mechanisms (11 papers), Neonatal Respiratory Health Research (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Synthesis of β-Lactam Compounds (9 papers), Inhalation and Respiratory Drug Delivery (8 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Pharmacology (2.9k citations), Biochemistry (817 citations) and Anesthesiology and Pain Medicine (549 citations). Richard C. Hubbard has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Ronald G. Crystal, André M. Cantin, Gilbert Geis, Susan L. North, G A Fells, Peter C. Isakson, Tricia M. McKeever, Andrew Fogarty, John W. Hutchinson and Kenneth M. Verburg. Their work appears in journals such as Journal of Clinical Investigation, Journal of Applied Physiology, Lung Cancer, The American Journal of Medicine and The American Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact